Neurologic manifestations of ulcerative colitis

European Journal of Neurology

Volumn 14, Issue 5, 2007, Pages 483-493

  Scheid, R ^a,b   Teich, N ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

Autoimmunity; Demyelination; Inflammatory bowel disease; Neurologic disorders; Thromboembolism; Ulcerative colitis; Vasculitis

Indexed keywords

ETANERCEPT; INFLIXIMAB; NATALIZUMAB;

AUTONOMIC NEUROPATHY; CLINICAL FEATURE; DEMYELINATING DISEASE; DEMYELINATION; ENCEPHALOMYELITIS; EPILEPSY; HUMAN; LYMPHOMA; MELKERSSON ROSENTHAL SYNDROME; MYOPATHY; OPPORTUNISTIC INFECTION; OPTIC NEURITIS; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; RISK ASSESSMENT; SENSORIMOTOR NEUROPATHY; SPINAL CORD DISEASE; ULCERATIVE COLITIS; VIRUS LOAD; VIRUS REACTIVATION;

EID: 34247156579     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01718.x     Document Type: Review

References (120)

1. Podolsky DK. Inflammatory bowel disease. The New England Journal of Medicine 2002; 347: 417-429.
2. Friedman S, Blumberg RS. Inflammatory bowel disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine, 16th edn. New York: McGraw-Hill, 2005: 1776-1789.
3. Loftus EV Jr. Inflammatory bowel disease extending its reach. Editorial. Gastroenterology 2005; 129: 1117-1120.
4. Sloan WP Jr, Bargen JA, Gage RP. Life histories of patients with chronic ulcerative colitis: a review of 2000 cases. Gastroenterology 1950: 16: 25-38.
5. Nugent FW, Rudolph NE. Extracolonic manifestations of ulcerative colitis. Medical Clinics of North America 1966; 50: 529-534.
6. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-412.
7. Monsen U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. American Journal of Gastroenterology 1990; 85: 711-716.
8. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. American Journal of Gastroenetrology 2001; 96: 1116-1122.
9. Rogler G, Schölmerich J. Extraintestinal manifestations of inflammatory bowel disease [German]. Medizinische Klinik 2004; 99: 123-130.
10. Danese S, Semeraro S, Papa A, et al. Extraintestinal manifetations in inflammatory bowel disease. World Journal of Gastroenterology 2005; 11: 7227-7236.
11. Mintz R, Feller ER, Bahr RI, Shah SA. Occular manifestations of inflammatory bowel disease. Inflammatory Bowel Diseases 2004; 10: 135-139.
12. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastoenterology 2005; 129: 827-836.
13. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflammatory Bowel Diseases 2003; 9: 104-115.
14. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Annals of Internal Medicine 2000; 133: 795-799.
15. Hoffmann RM, Kruis W. Rare extraintestinal manifestations of inflammatory bowel disease. Inflammatory Bowel Diseases 2004; 10: 140-147.
16. Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. The Quarterly Journal of Medicine 1989; 72: 835-840.
17. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thrombosis Haemostasis 2001; 85: 430-434.
18. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-548.
19. Twig G, Zandmann-Goddard G, Szyper-Kravitz M, Schoenfeld Y. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Annals of the New York Academy of Sciences 2005; 1051: 166-173.
20. Lossos A, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45: 416-421.
21. Elsehety A, Bertorini TE. Neurologic and neuropsychiatric complications of Crohn's disease. The Southern Medical Journal 1997; 90: 606-610.
22. Gendelman S, Present D, Janowitz HD. Neurological complications of inflammatory bowel disease. Gastroenterology 1982; 82: 1065.
23. Pfeiffer RF. Neurologic dysfunction in gastrointestinal disease. Seminars in Neurology 1996; 16: 217-226.
24. Skeen MB. Neurologic manifestations of gastrointestinal disease. Neurological Clinics 2002; 20: 195-225.
25. Wills AJ, Penigran Tengah DS, Holmes GK. The neurology of enteric disease. Journal of Neurology, Neurosurgery, and Psychiatry 2006, 77: 805-810.
26. Konturek SJ, Konturek JW, Pawlik T, Brzozowiki T. Brain-gut axis and its role in the control of food intake. Journal of Physiology and Pharmacology 2004; 55: 137-154.
27. Derbyshire SW. A systematic review of neuroimaging data during visceral stimulation. American Journal of Gastroenterology 2003; 98: 12-20.
28. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacological Reports 2005; 57: 23-34.
29. Gondim FA, Brannagan II, Sander HW, et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 2005; 128: 867-879.
30. Konagaya Y, Konagaya M, Takayanagi T. Chronic polyneuropathy and ulcerative colitis. Japan Journal of Medicine 1989; 28: 72-74.
31. Zimmermann J, Steiner I, Gavish D, Argov Z. Guillan-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis. Journal of Clinical Gastroneterology 1985; 7: 301-303.
32. Zincone A, Bogliun G, Crespi V, et al. Autonomic neuropathy in ulcerative colitis. Scand J Gastroenterol 1995; 30: 399-400.
33. Straub RH, Antoniou E, Zeuner M, Gross V, Scholmerich J, Andus T. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis. Journal of Neuroimmunology 1997; 80: 149-157.
34. Sedwick LA, Klingele TG, Burde RM, Behrens MM. Optic neuritis in inflammatory bowel disease. Journal of Clinical Neuroophtalmology 1984; 4: 3-6.
35. Nemoto H, Iguchi H, Ichikawa Y, et al. Ulcerative colitis presenting as sensorineural deafness, brainstem encephalopathy, and white matter lesions. Neurologist 2004; 10: 165-168.
36. Hollanders D. Sensorineural deafness - a new complication of ulcerative colitis? Postgraduate Medical Journal 1986; 62: 753-755.
37. Mathews J, Rao S, Kumar BN, Phil M. Autoimmune sensorineural hearing loss: is it still a clinical diagnosis? The Journal of Laryngology and Otology 2003; 117: 212-214.
38. Morí s G, Milla A, Ribacoba R, González C. Acute deafness as an extraintestinal manifestation of ulcerative colitis. European Journal of Internal Medicine 2005; 16: 440-442.
39. Kumar BN, Smith MSH, Walsh RM, Green JRB. Sensorineural hearing loss in ulcerative colitis. Clinical Otolaryngology 2000; 25: 143-145.
40. Akbayir N, Caliş AB, Alkim C, et al. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Digestive Diseases and Sciences 2005; 50: 1938-1945.
41. Bhigjee AI, Bill PL, Cosnett JE. Ulcerative colitis and interstitial myositis. Clinical Neurology and Neurosurgery 1987; 89: 261-263.
42. Sowa JM. Overlapping polymyositis and ulcerative colitis: HTLV-1 infection as an alternative explanation. Journal of Rheumatology 1991; 18: 1939.
43. Crespi V, Bogliun G, Marzorati L, et al. Inflammatory bowel disease and peripheral neuropathy. Journal of Neurology 1994; 241(Suppl. 1): 63.
44. Bargen JA, Nelson WB. Extensive arterial and venous thrombosis complicating ulcerative colitis. Archives of Internal Medicine 1936; 58: 17-31.
45. Kehoe EL, Newcomer KL. Thromboembolic phenomena in ulcerative colitis. Two case reports. Archives of Internal Medicine 1964; 113: 711-715.
46. Hilton-Jones D, Warlow CP. The causes of stroke in the young. Journal of Neurology 1985; 232: 137-143.
47. Nelson J, Barron MM, Riggs JE, et al. Cerebral vasculitis and ulcerative colitis. Neurology 1986; 36: 719-721.
48. Johns DR. Cerebrovascular complications of inflammatory bowel disease. American Journal of Gastroenterology 1991; 86: 367-370.
49. Derdeyn CP, Powers WJ. Isolated cortical venous thrombosis and ulcerative colitis. AJNR American Journal of Neuroradiology 1998; 19: 488-490.
50. Keene DL, Matzinger MA, Jacob PJ, Humphreys P. Cerebral vascular events associated with ulcerative colitis in children. Pediatric Neurology 2001; 24: 238-243.
51. Mayeux R, Fahn S. Strokes and ulcerative colitis. Neurology 1978; 28: 571-574.
52. Schneidermann JH, Sharpe JA, Sutton DM. Cerebral and retinal vascular complications of inflammatory bowel disease. Annals of Neurology 1979; 5: 331-337.
53. Gonzáles JL, Egido JA, Martínez P, Antón R. Cerebrovascular manifestations of gastrointestinal diseases [Spanish]. Reviews of Neurology 1995; 23(Suppl. 1): S91-S94.
54. Graef V, Baggenstoss AH, Sauer WG, Spittell JA. Venous thrombosis occurring in nonspecific ulcerative colitis. Archives of Internernal Medicine 1966; 117: 377-382.
55. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clinical Proceedings 1986; 61: 140-145.
56. Lossos A, Steiner I. Cerebrovascular disease in inflammatory bowel disease. In: Bogousslavsky J, Kaplan L, eds. Uncommon Causes of Stroke. Cambridge: Cambridge University Press, 2001: 161-168.
57. Fukuhara T, Tsuchida S, Kinugasa K, Ohmoto T. A case of pontine lacunar infarction with ulcerative colitis. Clinical Neurology and Neurosurgery 1993; 95: 159-162.
58. Scheid R, Hegenbart U, Ballaschke O, von Cramon DY. Major stroke in thrombotic-thrombocytopenic purpura (Moschcowitz-syndrome). Cerebrovascular Diseases 2004; 18: 83-85.
59. Baron BW, Jeon HR, Glunz C, et al. First two patients with ulcerative colitis who developed classic thrombotic thrombocytopenic purpura succesfully treated with medical therapy and plasma exchange. Journal of Clinical Apheresis 2002; 17: 204-206.
60. Hisada T, Miyamae Y, Mizuide M, et al. Acute thrombocytopenia associated with preexisting ulcerative colitis successfully treated with colectomy. Internal Medicine 2006; 45: 87-91.
61. Cattaneo M, Vecchi M, Zighetti ML, et al. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thrombosis Haemostasis 1998: 80: 542-545.
62. Oldenburg B, van Tuyl BA, van der Griend R, Fijnheer R, van Berge Henegouwen GP. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Digestive Diseases and Sciences 2005; 50: 235-240.
63. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. The New England Journal of Medicine 1998; 338: 1042-1050.
64. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomization. Lancet 2005; 365: 224-232.
65. Hassan A, Beverley JH, O'Sullivan MO, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-219.
66. Wang A, Mok V, Fan YH, Lam WW, Liang KS, Wong KS. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. Jounal of Neurology 2006; 253: 441-447.
67. Meadway J. Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis. Proceedings of the Royal Society of Medicine 1974; 67: 324-325.
68. Sclare AB, Geraghty BP. Therapeutic abortion: a follow-up study. Scottish Medical Journal 1971; 16: 438-442.
69. Mattsson A. Long-term physical illness in childhood: a challenge to psychosocial adaptation. Pediatrics 1972; 50: 801-811.
70. Holdsworth L, Whitmore K. A study of children with epilepsy attending ordinary schools. I: their seizure patterns, progress and behaviour in school. Developmental Medicine and Child Neurology 1974; 16: 746-758.
71. Hill O. The psychological management of psychosomatic diseases. British Journal of Psychiatry 1977; 131: 113-126.
72. Gibb WRG, Dhillon DP, Zilkha KJ, Cole PJ. Bronchiectasis with ulcerative colitis and myelopathy. Thorax 1987; 42: 155-156.
73. Ray DW, Bridger J, Hawnaur J, et al. Transverse myelitis as the presentation of Jo-1 antibody syndrome (myositis and fibrosing alveolitis) in long-standing ulcerative colitis. British Journal of Rheumatics 1993; 32: 1105-1108.
74. Suzuki I, Watanabe N, Suzuki J, Yamaguchi E, Munakata M, Fujita M. A case of bronchiectasis accompanied by ulcerative colitis (UC) and HTLV-1 associated myelopathy (HAM) [Japanese] Japanese. Journal of Thoracic Diseases 1994; 32: 358-363.
75. Takegoshi K, Nakanuma Y, Tsukada K, Okuda K. Human T-lymphotropic virus type 1-associated myelopathy and primary sclerosing cholangitis. Journal of Clinical Gastroenterology 1991; 13: 202-204.
76. Barbado FJ, Vazquez JJ, Gil A, Ortiz Vazquez J. Vasculitis and ulcerative colitis. Gastroenterology 1980, 79: 417-418.
77. Iannone F, Scioscia C, Musio A, Piscitelli D, Lapadula G. Leukocytoclastic vasculitis as onset symptom of ulcerative colitis. Annals of the Rheumatic Diseases 2003; 62: 785-786.
78. Kathiresan S, Kelsey PB, Steere CA, Foster CS, Curvelo MS, Stone JR. Case records of the Massachusetts General Hospital. Case 14-2005: a 38-year-old man with fever and blurred vision. The New England Journal of Medicine 2005; 352: 2003-2012.
79. Panani AD, Grigoriadou M, Magira E, Roussos C, Raptis SA. Perinuclear antineutrophil cytoplasmatic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis. Clinical Rheumatology 2005; 25: 35-37.
80. Friol-Verceletto M, Mussini JM, Bricout JH, Magne C. Ulcero-hemorrhagic rectocolitis. Possible manifestation, angiitis of the central nervous system [French]. Presse Medicine 1984; 13: 1218.
81. Carmona MA, Jaume Anselmi F, Ramirez Rivera J. Cerebral thrombosis and vasculitis: an uncommon complication of ulcerative colitis. Boletin - Asociation Medica de Puerto Rico 2000; 92: 9-11.
82. Pandian JD, Henderson RD, O'Sullivan JD, Rajah T. Cerebral vasculitis in ulcerative colitis. Archives of Neurology 2006; 63: 780.
83. Achar KN, Al-Nakib B. Takayashu's arteritis and ulcerative colitis. American Journal of Gastroenterology 1986; 81: 1215-1217.
84. Morita Y, Yamamura M, Suwaki K, et al. Takayashu's arteritis associated with ulcerative colitis; genetic factors in this association. Internal Medicine 1996; 35: 574-578.
85. Masuda H, Ishii U, Aoki N, et al. Ulcerative colitis associated with Takayashu's disease in two patients who received protocolectomy. Journal of Gastroenterology 2002; 37: 297-302.
86. Numano F, Miyata T, Nakajima T. Ulcerative colitis, Takayasu arteritis and HLA. Internal Medicine 1996; 35: 521-522.
87. Hokama A, Kinjo F, Arakaki T, et al. Pulseless hematochezia: Takayashu's arteritis associated with ulverative colitis. Internal Medicine 2003; 42: 897-898.
88. Glotzer DJ, Yuan RH, Patterson JF. Ulcerative colitis complicated by toxic megacolon, polyserositis and hemorrhagic leukoencephalitis with recovery. Annals of Surgery 1964; 159: 445-450.
89. Edwards KR. Hemorrhagic complications of cerebral arteritis. Archives of Neurology 1977; 34: 549-552.
90. Dejaco C, Fertl E, Prayer D, et al. Symptomatic cerebral microangiopathy preceding initial manifestation of ulcerative colitis. Digestive Diseases and Sciences 1996; 41: 1807-1810.
91. Masaki T, Tetsuichiro M, Shinozaki M, Kuroda T. Unusual cerebral complication associated with ulcerative colitis. Journal of Gastroenterology 1997; 32: 251-254.
92. Bartůňková J, Tesař V, Šedivá A. Diagnostic and pathogenic role of antineutrophil cytoplasmatic autoantibodies. Clinical Immunology 2003; 106: 73-82.
93. Kraus JA, Nahser HC, Berlit P. Lymphocytic encephalomyeloneuritis as a neurologic complication of ulcerative colitis. Journal of Neurological Sciences 1996; 141: 117-119.
94. Druschky A, Heckmann JG, Druschky K, et al. Severe neurological complications of ulcerative colitis. Journal of Clinical Neurosciences 2002; 9: 84-86.
95. Garg RK. Acute disseminated encephalomyelitis. Postgraduate Medical Journal 2003; 79: 11-17.
96. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis: an update. Archives of Neurology 2005; 62: 1673-1680.
97. Velin ÅK, Ericson AC, Braaf Y, et al. Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut 2004; 53: 494-500.
98. Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet 1982; 2: 555.
99. Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease. The New England Journal of Medicine 1986; 314: 586.
100. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease. The New England Journal of Medicine 1989; 321: 762-763.
101. Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005; 129: 819-826.
102. Geissler A. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995; 345: 897-898.
103. Hart PE, Gould SR, MacSweeney JE, et al. Brain white-matter lesions in inflammatory bowel disease. Lancet 1998; 351: 1158.
104. Gold R, Kappos L, Becker T. Development of multiple sclerosis in patient on long-term sulfasalazine. Lancet 1990; 335: 409-410.
105. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Annals of Neurology 2000; 47: 831-835
106. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Annals of Neurology 2005; 58: 840-846.
107. Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis. A follow-up study of 40 adult patients. Neurology 2001; 56: 1313-1318.
108. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000; 123: 2407-2422.
109. Sheffield WD, Squire RA, Strandberg JD. Cerebral venous thrombosis in the rhesus monkey. Veterinary Pathology 1981; 18: 326-334.
110. Van Bogaert L, Innes JR. Neurologic diseases of apes and monkeys. In: Innes JR, Saunders LZ, eds. Comparative Neuropathology. New York: Academic Press, 1962: 67-75.
111. Rutgeerts P, Sanborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. The New England Journal of Medicine 2005; 353: 2462-2476.
112. Ghosh S, Goldin E, Gordon FH, et al. Natalizumab for active Crohn's disease. The New England Journal of Medicine 2003; 348: 24-32.
113. 7integrin. The New England Journal of Medicine 2005; 352: 2499-2507.
114. Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha for inflammatory arthitides. Arthritis Rheumatics 2001; 44: 2862-2869.
115. Thomas CW Jr, Weinshenker BG, Sandborn WJ. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease. Inflammatory Bowel Diseases 2004; 10: 28-31.
116. Mejico L. Infliximab-associated retrobulbar optic neuritis. Archives of Ophtalmology 2004; 122: 793-794.
117. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infiximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology 2004; 126: 19-31.
118. Van Assche G, Van Ranst M, Sciot R et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. The New England Journal of Medicine 2005; 353: 362-368.
119. Berger JR, Koralnik IJ. Progressive multifocal leukoencephalopathy and natalizumab - unforeseen consequences. The New England Journal of Medicine 2005; 353: 414-416.
120. Ropper AH. Selective treatment of multiple sclerosis. Editorial. The New England Journal of Medicine 2006; 354: 965-967.